Teratogenic Impact of Dioxin Activated AHR in Laboratory Animals

The AH Receptor in Biology and Toxicology

Volumn , Issue , 2011, Pages 257-266

  Abbott, Barbara D ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

AHR expression, TCDD of CP, HN; AHR, ARNT, and AHR signaling; Dioxin activated AHR, teratogenic

Indexed keywords

EID: 84885964561     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118140574.ch17     Document Type: Chapter

References (74)

1. Kransler, K. M., McGarrigle, B. P., and Olson, J. R. (2007). Comparative developmental toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the hamster, rat and guinea pig. Toxicology, 229, 214-225.
2. Brouwer, A., Ahlborg, U. G., Van den Berg, M., Birnbaum, L. S., Boersma, E. R., Bosveld, B., Denison, M. S., Gray, L. E., Hagmar, L., Holene, E., et al. (1995). Functional aspects of developmental toxicity of polyhalogenated aromatic hydrocarbons in experimental animals and human infants. European Journal of Pharmacology, 293, 1-40.
3. Couture, L. A., Abbott, B. D., and Birnbaum, L. S. (1990). A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: recent advances toward understanding the mechanism. Teratology, 42, 619-627.
4. Birnbaum, L. S., Weber, H., Harris, M. W., Lamb, J. C., IV., and McKinney, J. D. (1985). Toxic interaction of specific polychlorinated biphenyls and 2,3,7,8-tetrachlorodibenzo-pdioxin: increased incidence of cleft palate in mice. Toxicology and Applied Pharmacology, 77, 292-302.
5. Courtney, K. D. and Moore, J. A. (1971). Teratology studies with 2,4,5-trichlorophenoxyacetic acid and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology, 20, 396-403.
6. Neubert, D., Zens, P., Rothenwallner, A., and Merker, H. J. (1973). A survey of the embryotoxic effects of TCDD in mammalian species. Environmental Health Perspectives, 5, 67-79.
7. Couture, L. A., Harris, M. W., and Birnbaum, L. S. (1990). Characterization of the peak period of sensitivity for the induction of hydronephrosis in C57BL/6N mice following exposure to 2,3,7, 8-tetrachlorodibenzo-p-dioxin. Fundamental and Applied Toxicology, 15, 142-150.
8. Couture-Haws, L., Harris, M.W., McDonald, M. M., Lockhart, A. C., and Birnbaum, L. S. (1991). Hydronephrosis in mice exposed to TCDD-contaminated breast milk: identification of the peak period of sensitivity and assessment of potential recovery. Toxicology and Applied Pharmacology, 107, 413-428.
9. Couture-Haws, L., Harris, M. W., Lockhart, A. C., and Birnbaum, L. S. (1991). Evaluation of the persistence of hydronephrosis induced in mice following in utero and/or lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology, 107, 402-412.
10. Abbott, B. D., Birnbaum, L. S., and Pratt, R. M. (1987). TCDDinduced hyperplasia of the ureteral epithelium produces hydronephrosis in murine fetuses. Teratology, 35, 329-334.
11. Abbott, B. D., Morgan, K. S., Birnbaum, L. S., and Pratt, R. M. (1987). TCDD alters the extracellular matrix and basal lamina of the fetal mouse kidney. Teratology, 35, 335-344.
12. Nishimura, N., Matsumura, F., Vogel, C. F., Nishimura, H., Yonemoto, J., Yoshioka, W., and Tohyama, C. (2008). Critical role of cyclooxygenase-2 activation in pathogenesis of hydronephrosis caused by lactational exposure of mice to dioxin. Toxicology and Applied Pharmacology, 231, 374-383.
13. Abbott, B. D. and Birnbaum, L. S. (1989). TCDD alters medial epithelial cell differentiation during palatogenesis. Toxicology and Applied Pharmacology, 99, 276-286.
14. Meng, L., Bian, Z., Torensma, R., and Von den Hoff, J. W. (2009). Biological mechanisms in palatogenesis and cleft palate. Journal of Dental Research, 88, 22-33.
15. Pratt, R. M., Dencker, L., and Diewert, V. M. (1984). 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced cleft palate in the mouse: evidence for alterations in palatal shelf fusion. Teratogenesis, Carcinogenesis, and Mutagenesis, 4, 427-436.
16. Abbott, B. D., Birnbaum, L. S., and Perdew, G. H. (1995). Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo. Developmental Dynamics, 204, 133-143.
17. Abbott, B. D. and Probst, M. R. (1995). Developmental expression of two members of a newclass of transcription factors: II. Expression of aryl hydrocarbon receptor nuclear translocator in the C57BL/6N mouse embryo. Developmental Dynamics, 204, 144-155.
18. Mimura, J., et al. (1997). Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes to Cells, 2, 645-654.
19. Jain, S., Maltepe, E., Lu, M. M., Simon, C., and Bradfield, C. A. (1998). Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha and Ah receptor mRNAs in the developing mouse. Mechanisms of Development, 73, 117-123.
20. Abbott, B. D., Perdew, G. H., and Birnbaum, L. S. (1994). Ah receptor in embryonic mouse palate and effects of TCDD on receptor expression. Toxicology and Applied Pharmacology, 126, 16-25.
21. Abbott, B. D., Schmid, J. E., Brown, J. G.,Wood, C. R., White, R. D., Buckalew, A. R., and Held, G. A. (1999). RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicological Sciences, 47, 76-85.
22. Bryant, P. L., Clark, G. C., Probst, M. R., and Abbott, B. D. (1997). Effects of TCDD on Ah receptor, ARNT, EGF, and TGF-alpha expression in embryonic mouse urinary tract. Teratology, 55, 326-337.
23. Abbott, B. D., Buckalew, A. R., Diliberto, J. J., Wood, C. R., Held, G., Pitt, J. A., and Schmid, J. E. (1999). AhR, ARNT, and CYP1A1 mRNA quantitation in cultured human embryonic palates exposed to TCDD and comparison with mouse palate in vivo and in culture. Toxicological Sciences, 47, 62-75.
24. Abbott, B. D., Probst, M. R., Perdew, G. H., and Buckalew, A. R. (1998). AH receptor, ARNT, glucocorticoid receptor, EGF receptor, EGF, TGF alpha, TGF beta 1, TGF beta 2, and TGF beta 3 expression in human embryonic palate, and effects of2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Teratology, 58, 30-43.
25. Abbott, B. D., Birnbaum, L. S., and Diliberto, J. J. (1996). Rapid distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) to embryonic tissues in C57BL/6N mice and correlation with palatal uptake in vitro. Toxicology and Applied Pharmacology, 141, 256-263.
26. Hurst, C. H., Abbott, B. D., DeVito, M. J., and Birnbaum, L. S. (1998). 2,3,7,8-Tetrachlorodibenzo-p-dioxin in pregnant Long Evans rats: disposition to maternal and embryo/fetal tissues. Toxicological Sciences, 45, 129-136.
27. Willey, J. J., Stripp, B. R., Baggs, R. B., and Gasiewicz, T. A. (1998). Aryl hydrocarbon receptor activation in genital tubercle, palate, and other embryonic tissues in 2,3,7, 8-tetrachlorodibenzo-p-dioxin-responsive lacZ mice. Toxicology and Applied Pharmacology, 151, 33-44.
28. Fernandez-Salguero, P. M., Ward, J. M., Sundberg, J. P., and Gonzalez, F. J. (1997). Lesions of aryl-hydrocarbon receptordeficient mice. Veterinary Pathology, 34, 605-614.
29. Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C., and Bradfield, C. A. (1996). Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proceedings of the National Academy of Sciences of the United States of America, 93, 6731-6736.
30. Peters, J. M., Narotsky, M. G., Elizondo, G., Fernandez-Salguero, P. M., Gonzalez, F. J., and Abbott, B. D. (1999). Amelioration of TCDD-induced teratogenesis in aryl hydrocarbon receptor (AhR)-null mice. Toxicological Sciences, 47, 86-92.
31. Thomae,T. L.,Glover,E.,andBradfield,C.A.(2004).Amaternal Ahr null genotype sensitizes embryos to chemical teratogenesis. Journal of Biological Chemistry, 279, 30189-30194.
32. Dragin, N., Dalton, T. P., Miller, M. L., Shertzer, H. G., and Nebert, D. W. (2006). For dioxin-induced birth defects, mouse or human CYP1A2 in maternal liver protects whereas mouse CYP1A1 and CYP1B1 are inconsequential. Journal of Biological Chemistry, 281, 18591-18600.
33. Bunger,M. K., Moran, S. M., Glover, E., Thomae, T. L., Lahvis, G. P., Lin, B. C., and Bradfield, C. A. (2003). Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor. Journal of Biological Chemistry, 278, 17767-17774.
34. Bunger,M. K., Glover, E., Moran, S. M.,Walisser, J. A., Lahvis, G. P., Hsu, E. L., and Bradfield, C. A. (2008). Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-pdioxin toxicity in mice carrying a mutation in the DNA-binding domain of the aryl hydrocarbon receptor. Toxicological Sciences, 106, 83-92.
35. Jang, J. Y., et al. (2008). Antiteratogenic effect of resveratrol in mice exposed in utero to 2,3,7,8-tetrachlorodibenzo-p-dioxin. European Journal of Pharmacology, 591, 280-283.
36. Jang, J. Y., et al. (2007). Antiteratogenic effects of alphanaphthoflavone on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposed mice in utero. Reproductive Toxicology, 24, 303-309.
37. Dolwick, K. M., Schmidt, J. V., Carver, L. A., Swanson, H. I., and Bradfield, C. A. (1993). Cloning and expression of a human Ah receptor cDNA. Molecular Pharmacology, 44, 911-917.
38. Hoffman, E. C., Reyes, H., Chu, F. F., Sander, F., Conley, L. H., Brooks, B. A., and Hankinson, O. (1991). Cloning of a factor required for activity of the Ah (dioxin) receptor. Science, 252, 954-958.
39. Abbott, B. D. and Birnbaum, L. S. (1991). TCDD exposure of human embryonic palatal shelves in organ culture alters the differentiation of medial epithelial cells. Teratology, 43, 119-132.
40. Abbott, B. D., Held, G. A., Wood, C. R., Buckalew, A. R., Brown, J. G., and Schmid, J. (1999). AhR,ARNT, and CYP1A1 mRNA quantitation in cultured human embryonic palates exposed to TCDD and comparison with mouse palate in vivo and in culture. Toxicological Sciences, 47, 62-75.
41. Abbott, B. D., Probst, M. R., and Perdew, G. H. (1994). Immunohistochemical double-staining for Ah receptor and ARNT in human embryonic palatal shelves. Teratology, 50, 361-366.
42. Schecter, A., Startin, J., Wright, C., Papke, O., Ball, M., and Lis, A. (1996). Concentrations of polychlorinated dibenzo-p-dioxins and dibenzofurans in human placental and fetal tissues from the U. S. in placentas fromYu-Cheng exposed mothers. Chemosphere, 32, 551-557.
43. Moriguchi, T., et al. (2003). Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse. Proceedings of the National Academy of Sciences of the United States of America, 100, 5652-5657.
44. Ema, M., Ohe, N., Suzuki, M., Mimura, J., Sogawa, K., Ikawa, S., and Fujii-Kuriyama, Y. (1994). Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors. Journal of Biological Chemistry, 269, 27337-27343.
45. Micka, J., Milatovich, A., Menon, A., Grabowski, G. A., Puga, A., and Nebert, D.W. (1997). Human Ah receptor (AHR) gene: localization to 7p15 and suggestive correlation of polymorphism with CYP1A1 inducibility. Pharmacogenetics, 7, 95-101.
46. Natsume, N., Kawai, T., and Le, H. (1998). In Vietnam, many congenital anomalies are believed to result from the scattering of defoliants, including dioxin. The Cleft Palate-Craniofacial Journal, 35, 183.
47. Gomez-Duran, A., Carvajal-Gonzalez, J. M., Mulero-Navarro, S., Santiago-Josefat, B., Puga, A., and Fernandez-Salguero, P. M. (2009). Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFb signaling. Biochemical Pharmacology, 77, 700-712.
48. Haarmann-Stemmann, T., Bothe, H., and Abel, J. (2009). Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways. Biochemical Pharmacology, 77, 508-520.
49. Kung, T., Murphy, K. A., and White, L. A. (2009). The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism. Biochemical Pharmacology, 77, 536-546.
50. Puga, A., Ma, C., and Marlowe, J. L. (2009). The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochemical Pharmacology, 77, 713-722.
51. Ma, C., Marlowe, J. L., and Puga, A. (2009). The aryl hydrocarbon receptor at the crossroads of multiple signaling pathways. EXS, 99, 231-257.
52. Chen, S., Operana, T., Bonzo, J., Nguyen, N., and Tukey, R. H. (2005). ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: implications for transcriptional activation and protein degradation. Journal of Biological Chemistry, 280, 4350-4359.
53. Tan, Z., Huang, M., Puga, A., and Xia, Y. (2004). A critical role for MAPkinases in the control of Ah receptor complex activity. Toxicological Sciences, 82, 80-87.
54. Ma, X. and Babish, J. G. (1999). Activation of signal transduction pathways by dioxins. In Molecular Biology of the Toxic Response (Puga, A. andWallace, K. B.,Eds). Taylor&Francis, Philadelphia, pp. 493-516.
55. Chang, X., Fan, Y., Karyala, S., Schwemberger, S., Tomlinson, C. R., Sartor, M. A., and Puga, A. (2007). Ligand-independent regulation of transforming growth factor b1 expression and cell cycle progression by the aryl hydrocarbon receptor. Molecular and Cellular Biology, 27, 6127-6139.
56. Fitzpatrick, D. R., Denhez, F., Kondaiah, P., and Akhurst, R. J. (1990). Differential expression of TGF beta isoforms in murine palatogenesis. Development, 109, 585-595.
57. Brunet, C. L., Sharpe, P. M., and Ferguson, M. W. (1995). Inhibition of TGF-b3 (but not TGF-b1 or TGF-b2) activity prevents normal mouse embryonic palate fusion. International Journal of Developmental Biology, 39, 345-355.
58. Kaartinen, V., Cui, X. M., Heisterkamp, N., Groffen, J., and Shuler, C. F. (1997). Transforming growth factor-b3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associated degradation of the basement membrane. Developmental Dynamics, 209, 255-260.
59. Proetzel, G., et al. (1995). Transforming growth factor-b3 is required for secondary palate fusion. Nature Genetics, 11, 409-414.
60. Taya,Y., O'Kane, S., and Ferguson, M.W. (1999). Pathogenesis of cleft palate in TGF-b3 knockout mice. Development, 126, 3869-3879.
61. Thomae, T. L., Stevens, E. A., and Bradfield, C. A. (2005). Transforming growth factor-b3 restores fusion in palatal shelves exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Journal of Biological Chemistry, 280, 12742-12746.
62. Thomae, T. L., Stevens, E. A., Liss, A. L., Drinkwater, N. R., and Bradfield, C. A. (2006). The teratogenic sensitivity to 2,3,7,8-tetrachlorodibenzo-p-dioxin is modified by a locus on mouse chromosome 3. Molecular Pharmacology, 69, 770-775.
63. Abbott, B. D. and Birnbaum, L. S. (1998). Dioxins and teratogenesis. In Molecular Biology of the Toxic Response (Puga, A. and Wallace, K.,Eds). Taylor & Francis, Washington, DC, pp. 439-447.
64. Miettinen, H. M., Huuskonen, H., Partanen, A. M., Miettinen, P., Tuomisto, J. T., Pohjanvirta, R., and Tuomisto, J. (2004). Effects of epidermal growth factor receptor deficiency and2,3,7,8-tetrachlorodibenzo-p-dioxin on fetal development in mice. Toxicology Letters, 150, 285-291.
65. Abbott, B. D., Buckalew, A. R., and Leffler, K. E. (2005). Effects of epidermal growth factor (EGF), transforming growth factor-a (TGFa), and 2,3,7,8-tetrachlorodibenzo-p-dioxin on fusion of embryonic palates in serum-free organ culture using wild-type, EGF knockout, and TGFa knockout mouse strains. Birth Defects Research, Part A, 73, 447-454.
66. Hassell, J. R. (1975). The development of rat palatal shelves in vitro. An ultrastructural analysis of the inhibition of epithelial cell death and palate fusion by the epidermal growth factor. Developmental Biology, 45, 90-102.
67. Tyler,M. S. and Pratt, R. M. (1980). Effect of epidermal growth factor on secondary palatal epithelium in vitro: tissue isolation and recombination studies. Journal of Embryology and Experimental Morphology, 58, 93-106.
68. Yamamoto, T., Cui, X. M., and Shuler, C. F. (2003). Role of ERK1/2 signaling during EGF-induced inhibition of palatal fusion. Developmental Biology, 260, 512-521.
69. Patel, R. D., Kim, D. J., Peters, J.M., and Perdew, G. H. (2006). The aryl hydrocarbon receptor directly regulates expression of the potentmitogen epiregulin.Toxicological Sciences, 89, 75-82.
70. Abbott, B. D., Buckalew, A. R., DeVito, M. J., Ross, D., Bryant, P. L., and Schmid, J. E. (2003). EGF and TGF-a expression influence the developmental toxicity of TCDD: dose response and AhR phenotype in EGF, TGF-a, and EGF {Thorn} TGF-a knockout mice. Toxicological Sciences, 71, 84-95.
71. Bryant, P. L., Schmid, J. E., Fenton, S. E., Buckalew, A. R., and Abbott, B. D. (2001). Teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the expression of EGF and/or TGF-a. Toxicological Sciences, 62, 103-114.
72. Abbott, B. D. and Birnbaum, L. S. (1990). Effects of TCDD on embryonic ureteric epithelial EGF receptor expression and cell proliferation. Teratology, 41, 71-84.
73. Abbott, B. D., Harris, M. W., and Birnbaum, L. S. (1992). Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into their interaction in the embryonic mouse palate. Teratology, 45, 35-53.
74. Abbott, B. D., Perdew, G. H., Buckalew, A. R., and Birnbaum, L. S. (1994). Interactive regulation of Ah and glucocorticoid receptors in the synergistic induction of cleft palate by 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicology and Applied Pharmacology, 128, 138-150.